Centaura

Centaura was founded in 2018. Next year, in 2019, Centaura AG was registered in Switzerland, Zurich, and in 2021 Centaura Inc. — in USA, Boston.

The rapid advance of technology has made what was thought impossible just 10 years ago now possible — and this progress shows no sign of slowing down. Soon, technology will alter not only our everyday lives, but the very concept of what it means to be human giving new instructions to cells.

Centaura, an early-stage biotech company, aims to prevent and reverse aging, keeping people healthy and functional both cognitively and physically, by studying the biological origins of aging-related processes and developing targeted therapies to combat their root causes. We work with scientists at the forefront of aging research from the world’s top academic institutions.

Currently, Centaura undergoes successful seed-round fundraising, seeking $10M and getting positive feedback from well-known investment funds as well as from private investors.